Gemcitabine Injection

Gemcitabine Hydrochloride is a nucleoside analogue antineoplastic supplied as an injection. It is used in standard clinical practice for pancreatic cancer, non-small cell lung cancer and bladder cancer, as described in general pharmacological references.

Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.